CAM
CLLS

Cormorant Asset Management’s Cellectis CLLS Stock Holding History

Cormorant Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-498,117
Closed -$12M – 81
2016
Q3 		$12M Hold
498,117
– – 1.32% 25
2016
Q2 		$13.2M Buy
498,117
+28,972
+6% +$849K 1.88% 18
2016
Q1 		$12.9M Hold
469,145
– – 1.94% 16
2015
Q4 		$14.6M Buy
469,145
+457,845
+4,052% +$13.9M 1.74% 20
2015
Q3 		$298K Hold
11,300
– – 0.05% 85
2015
Q2 		$408K Sell
11,300
-13,700
-55% -$481K 0.05% 78
2015
Q1 		$865K Buy
+25,000
New +$907K 0.13% 64

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cormorant Asset Management's CLLS Position: Q4 2016 in Review

Cormorant Asset Management sold out of Cellectis (CLLS) in Q4 2016, closing a stake of 498,117 shares — an estimated $12M sold.

Cormorant Asset Management first reported a position in CLLS in Q1 2015 and held it in 7 quarters. The position peaked at $14.6M in Q4 2015. 37 funds tracked by Wall St. Rank hold CLLS as of Q4 2016.

  • Cormorant Asset Management reported no remaining Cellectis position as of Q4 2016 after selling out during the quarter.
  • Cormorant Asset Management sold 498,117 Cellectis shares in Q4 2016, an estimated $12M.
  • Cormorant Asset Management first reported a position in Cellectis in Q1 2015 and held it in 7 quarters.
  • Cormorant Asset Management's Cellectis position peaked at $14.6M in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Cellectis as of Q4 2016.

Based on Cormorant Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.